Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 50-43-1 | MDL No. : | MFCD00060699 |
Formula : | C7H3Cl3O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | RAFFVQBMVYYTQS-UHFFFAOYSA-N |
M.W : | 225.46 | Pubchem ID : | 5764 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 48.43 |
TPSA : | 37.3 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.64 cm/s |
Log Po/w (iLOGP) : | 1.62 |
Log Po/w (XLOGP3) : | 2.86 |
Log Po/w (WLOGP) : | 3.35 |
Log Po/w (MLOGP) : | 3.36 |
Log Po/w (SILICOS-IT) : | 3.16 |
Consensus Log Po/w : | 2.87 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -3.34 |
Solubility : | 0.102 mg/ml ; 0.000453 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.3 |
Solubility : | 0.112 mg/ml ; 0.000499 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.63 |
Solubility : | 0.0532 mg/ml ; 0.000236 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.28 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | Stage #1: With borane-dimethyl sulfide complex In tetrahydrofuran at 22℃; Inert atmosphere; Cooling with ice; Reflux Stage #2: With methanol In tetrahydrofuran |
Step 1 ) 1 4To a solution of commercially available compound 1 (22.5 g, 0.1 mol) in THF (200 mL) was added BH3-Me2S (10 M, 20 mL, 0.2 mol) under N2 with ice-cooling. The mixture was allowed to warm to 22°C and stirred overnight under reflux. Methanol (100 mL) was added drop-wise and the resulting mixture stirred for 16 g. The mixture was concentrated in vacuo to afford compound 4 (22.7 g, 100percent) as a white solid. 1H NMR (CDCIs 400MHz): ? 7.37 (s, 2H), 4.93 (d, 2H, J=6.8 Hz). |
[ 83277-23-0 ]
2,4-Dichloro-3-methylbenzoic acid
Similarity: 0.96
[ 153203-80-6 ]
3,5-Dichloro-4-formylbenzoic acid
Similarity: 0.94
[ 83277-23-0 ]
2,4-Dichloro-3-methylbenzoic acid
Similarity: 0.96
[ 153203-80-6 ]
3,5-Dichloro-4-formylbenzoic acid
Similarity: 0.94
[ 83277-23-0 ]
2,4-Dichloro-3-methylbenzoic acid
Similarity: 0.96
[ 153203-80-6 ]
3,5-Dichloro-4-formylbenzoic acid
Similarity: 0.94